US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Centessa Pharmaceuticals plc

12.60

+0.22001.78%

Post-market: 12.600.00000.00%17:59 EDT

Volume:1.26M

Turnover:15.69M

Market Cap:1.68B

PE:-6.91

High:12.69

Open:12.44

Low:12.05

Close:12.38

Loading ...

Overview Company News Filings

Centessa Pharmaceuticals Receives FDA Clearance for Phase 1 Clinical Study of ORX142, a Novel Orexin Receptor 2 Agonist

Leerink Partners Remains a Buy on Centessa Pharmaceuticals (CNTA)

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live

Centessa Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Raphael Deferiere

Centessa Pharmaceuticals Appoints Raphael Deferiere as Chief Accounting Officer

Needham Initiates Centessa Pharmaceuticals ADR at Buy With $35 Price Target

MT Newswires Live

Centessa initiated with a Buy at Needham

Centessa Pharmaceuticals Initiated at Buy by Needham

Centessa Pharmaceuticals (CNTA) Receives a Buy from Piper Sandler

Director Arjun Goyal Reports Acquisition of Common Shares in Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Jefferies 2025 Global Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE)

Centessa Pharmaceuticals Posts Revenue, Q1 Net Loss Narrows

MT Newswires Live

Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M

MT Newswires Live

Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss

MT Newswires Live

Centessa Pharmaceuticals Q1 EPS $(0.20) Beats $(0.37) Estimate, Sales $15.00M

Centessa Pharmaceuticals Reports Q1 2025 Results: Net Loss Narrows to $26.1M, R&D Expenses Increase by 47%

Press Release: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Centessa Pharmaceuticals Initiated at Buy by Chardan Capital

Chardan Initiates Centessa Pharmaceuticals at Buy With $30 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNTA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNTA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTA\",,,,,undefined,":{"symbol":"CNTA","market":"US","secType":"STK","nameCN":"Centessa Pharmaceuticals plc","latestPrice":12.6,"timestamp":1750104000000,"preClose":12.38,"halted":0,"volume":1256725,"hourTrading":{"tag":"盘后","latestPrice":12.6,"preClose":12.6,"latestTime":"17:59 EDT","volume":194662,"amount":2452741.1999999997,"timestamp":1750111188377},"delay":0,"floatShares":86152495,"shares":133618774,"eps":-1.823445,"marketStatus":"Post-Mkt","change":0.22,"latestTime":"06-16 18:44:28 EDT","open":12.44,"high":12.69,"low":12.05,"amount":15687943.236375,"amplitude":0.051696,"askPrice":15.44,"askSize":100,"bidPrice":10.88,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.823445,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750118400000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1622174400000,"exchange":"NASDAQ","adjPreClose":12.38,"preHourTrading":{"tag":"盘前","latestPrice":13,"preClose":12.38,"latestTime":"09:29 EDT","volume":124,"amount":1610.4798839999999,"timestamp":1750080583738},"postHourTrading":{"tag":"盘后","latestPrice":12.6,"preClose":12.6,"latestTime":"17:59 EDT","volume":194662,"amount":2452741.1999999997,"timestamp":1750111188377},"volumeRatio":1.060409,"impliedVol":1.2521,"impliedVolPercentile":0.984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTA\",,,,,undefined,":{"symbol":"CNTA","floatShares":86152495,"roa":"-28.58%","roe":"-74.44%","lyrEps":-2.05949,"volumeRatio":1.060409,"shares":133618774,"dividePrice":0,"high":12.69,"amplitude":0.051696,"preClose":12.38,"low":12.05,"week52Low":8.46,"pbRate":"4.36","psRate":"112.24","week52High":19.09,"institutionHeld":0,"latestPrice":12.6,"eps":-1.823445,"divideRate":0,"volume":1256725,"delay":0,"ttmEps":-1.823445,"open":12.44,"prevYearClose":16.75,"prevWeekClose":12.38,"prevMonthClose":13.51,"prevQuarterClose":14.38,"fiveDayClose":11.94,"twentyDayClose":12.51,"sixtyDayClose":16.29},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNTA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543703166","title":"Centessa Pharmaceuticals Receives FDA Clearance for Phase 1 Clinical Study of ORX142, a Novel Orexin Receptor 2 Agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2543703166","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543703166?lang=en_us&edition=fundamental","pubTime":"2025-06-16 21:01","pubTimestamp":1750078863,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals plc has announced that the U.S. Food and Drug Administration  has cleared their Investigational New Drug Application  for ORX142, a novel Orexin Receptor 2  agonist. This clearance allows Centessa to initiate a Phase 1 clinical study of ORX142, aimed at treating select neurological and neurodegenerative disorders. The study will focus on acutely sleep-deprived healthy volunteers to assess the safety, tolerability, and pharmacokinetics of the drug. This approval marks a significant milestone for Centessa, as they explore ORX142's potential to address unmet needs beyond rare hypersomnias. The clinical data from this study is expected later this year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centessa Pharmac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nNDL3ztkLz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","LU2210149790.SGD","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4588","BK4535","NDAQ","CNTA","BK4539","BK4139","LU2095319765.USD"],"gpt_icon":0},{"id":"2542064593","title":"Leerink Partners Remains a Buy on Centessa Pharmaceuticals (CNTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2542064593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542064593?lang=en_us&edition=fundamental","pubTime":"2025-06-12 15:45","pubTimestamp":1749714308,"startTime":"0","endTime":"0","summary":"In a report released on June 9, David Risinger from Leerink Partners reiterated a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report), ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-buy-on-centessa-pharmaceuticals-cnta-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-remains-a-buy-on-centessa-pharmaceuticals-cnta-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4535","CNTA"],"gpt_icon":0},{"id":"2541071753","title":"European Equities Traded in the US as American Depositary Receipts Rise Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2541071753","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541071753?lang=en_us&edition=fundamental","pubTime":"2025-06-05 23:22","pubTimestamp":1749136943,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were advancing on Thursday morning, up 0.7% to 1,476.59 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by healthcare company Grifols  and financial services provider Banco Santander , which rose 3.2% and 1.9% respectively.They were followed by steel manufacturer ArcelorMittal , which added 1.7%, and semiconductor company ASML , which increased 1.5%.The decliners from continental Europe were led by biotech company Evaxion  and cybersecurity firm Wisekey , which fell 4.3% and 2.2% respectively.They were followed by advertising company Criteo , down 2%.From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics  and cigarette manufacturer British American Tobacco , which rose 3.6% and 2.6% respectively.The decliners from the UK and Ireland were led by biotech firm Centessa Pharmaceuticals   and beverage giant Diageo , which lost 7.8% and 3.9% respectively.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4009","BK4539","BK4075","BK4139","BK4559","LU0823434740.USD","LU2063271972.USD","SAN","BK7142","BK4207","AUTL","BK4117","AFG","LU0097036916.USD","DGE.UK","SAN.AU","LU1734074674.USD","IE00BD6J9T35.USD","LU2543165471.USD","BTI.AU","BK4585","BK4561","LU0823434583.USD","BK4169","BK4006","BK4535","CRTO","CNTA","BK4141","ASML","BK4543","WKEY","MT","BK4521","BK7062","BK4565","BK4107","GRFS","BTI","LU0345774391.USD","DEO","EVAX","LU0345774631.USD","IE0004445239.USD","03165","IE00BFMHRM44.USD","BK4147","BK4588"],"gpt_icon":1},{"id":"2540702803","title":"Centessa Pharmaceuticals Files Initial Statement of Beneficial Ownership for Chief Accounting Officer Raphael Deferiere","url":"https://stock-news.laohu8.com/highlight/detail?id=2540702803","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540702803?lang=en_us&edition=fundamental","pubTime":"2025-06-04 04:24","pubTimestamp":1748982274,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals plc has filed an initial statement of beneficial ownership. The filing lists Raphael Deferiere as the beneficial owner, who holds the position of Chief Accounting Officer at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centessa Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL3hkx9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4539","CNTA","BK4139"],"gpt_icon":0},{"id":"2539425033","title":"Centessa Pharmaceuticals Appoints Raphael Deferiere as Chief Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2539425033","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539425033?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:09","pubTimestamp":1748520554,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals plc has announced the appointment of Raphael Deferiere as the new Chief Accounting Officer, effective May 27, 2025. Deferiere takes over the role of principal accounting officer from John Crowley, who remains as the company's Chief Financial Officer. Deferiere joins Centessa from Ernst & Young, LLP, where he served as an Assurance Partner.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centessa Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL9yMQ0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA","BK4539","BK4139","BK4535"],"gpt_icon":0},{"id":"2538478300","title":"Needham Initiates Centessa Pharmaceuticals ADR at Buy With $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2538478300","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538478300?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:12","pubTimestamp":1748430759,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals ADR (CNTA) has an average rating of buy and mean price target of $31.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTA"],"gpt_icon":0},{"id":"2538141427","title":"Centessa initiated with a Buy at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2538141427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538141427?lang=en_us&edition=fundamental","pubTime":"2025-05-28 18:35","pubTimestamp":1748428508,"startTime":"0","endTime":"0","summary":"Needham initiated coverage of Centessa (CNTA) with a Buy rating and $35 price target Centessa’s ORX750 has a potentially best-in-class clinical pro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/centessa-initiated-with-a-buy-at-needham-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/centessa-initiated-with-a-buy-at-needham-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","CNTA","BK4539","BK4139"],"gpt_icon":0},{"id":"2538442718","title":"Centessa Pharmaceuticals Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2538442718","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538442718?lang=en_us&edition=fundamental","pubTime":"2025-05-28 18:35","pubTimestamp":1748428500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2025 06:35 ET (10:35 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4139","CNTA","BK4539"],"gpt_icon":0},{"id":"2536619196","title":"Centessa Pharmaceuticals (CNTA) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2536619196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536619196?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:45","pubTimestamp":1747737931,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Centessa Pharmaceuticals (CNTA – Research Report) today and set a price target of $38.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/centessa-pharmaceuticals-cnta-receives-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/centessa-pharmaceuticals-cnta-receives-a-buy-from-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","CNTA","BK4535","BK4139"],"gpt_icon":0},{"id":"2536580686","title":"Director Arjun Goyal Reports Acquisition of Common Shares in Centessa Pharmaceuticals plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2536580686","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536580686?lang=en_us&edition=fundamental","pubTime":"2025-05-20 05:49","pubTimestamp":1747691381,"startTime":"0","endTime":"0","summary":"Arjun Goyal, a Director at Centessa Pharmaceuticals plc, reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centessa Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDLPsj5V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4535","CNTA"],"gpt_icon":0},{"id":"2536689137","title":"Centessa Pharmaceuticals to Participate in Jefferies 2025 Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2536689137","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536689137?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:00","pubTimestamp":1747656028,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company focused on developing transformational medicines, is set to participate in the Jefferies 2025 Global Healthcare Conference on June 4, 2025. Members of the company's management team will engage in a fireside chat at 11:40 AM ET. Access to the live webcast and archived recordings will be available on the Centessa Pharmaceuticals website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centessa Pharmaceuticals plc published the original content used to generate this news brief via GlobeNewswire  on May 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL5XSs7H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA","IE00BKPKM429.USD","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","BK4539","BK4535","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2536503688","title":"Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Arcellx Inc (ACLX) and Belite Bio, Inc. ADR (BLTE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2536503688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536503688?lang=en_us&edition=fundamental","pubTime":"2025-05-19 16:20","pubTimestamp":1747642830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Centessa Pharmaceuticals (CNTA – Research Report), A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-centessa-pharmaceuticals-cnta-arcellx-inc-aclx-and-belite-bio-inc-adr-blte?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-centessa-pharmaceuticals-cnta-arcellx-inc-aclx-and-belite-bio-inc-adr-blte?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLTE","BK4539","BK4137","ACLX","BK4007","CNTA","BK4535","HCSG","BK4139"],"gpt_icon":0},{"id":"2535136028","title":"Centessa Pharmaceuticals Posts Revenue, Q1 Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2535136028","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535136028?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:32","pubTimestamp":1747222354,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals  reported a Q1 net loss Wednesday of $0.20 per diluted share, narrower than a loss of $0.38 a year earlier.Analysts polled by FactSet expected a loss of $0.33.License and other revenue for the quarter ended March 31 was $15 million.The company did not report any revenue a year earlier.As of March 31, the company said it had $424.9 million in cash, cash equivalents and investments, expected to fund operations into mid-2027.The company's shares were down 3.3% in recent Wednesday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTA"],"gpt_icon":0},{"id":"2535040827","title":"Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535040827","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535040827?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:18","pubTimestamp":1747221485,"startTime":"0","endTime":"0","summary":"Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 License and Other Revenue of $15M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTA"],"gpt_icon":0},{"id":"2535824040","title":"Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2535824040","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535824040?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:16","pubTimestamp":1747221377,"startTime":"0","endTime":"0","summary":"Earnings Flash (CNTA) Centessa Pharmaceuticals Posts Q1 Net Loss $0.20 a Share, vs. FactSet Est of $0.37 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTA"],"gpt_icon":0},{"id":"2535047839","title":"Centessa Pharmaceuticals Q1 EPS $(0.20) Beats $(0.37) Estimate, Sales $15.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535047839","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535047839?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:04","pubTimestamp":1747220654,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 47.37 percent increase over losses of $(0.38) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45402381/centessa-pharmaceuticals-q1-eps-0-20-beats-0-37-estimate-sales-15-00m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA"],"gpt_icon":0},{"id":"2535223042","title":"Centessa Pharmaceuticals Reports Q1 2025 Results: Net Loss Narrows to $26.1M, R&D Expenses Increase by 47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535223042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535223042?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:02","pubTimestamp":1747220535,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals plc reported financial results for the first quarter ended March 31, 2025. The company experienced a reduction in net loss, which was $26.1 million, compared to $38.0 million for the same period in 2024. Research and Development (R&D) expenses increased to $33.4 million from $22.7 million in the previous year. Conversely, General and Administrative (G&A) expenses decreased slightly to $12.3 million from $13.4 million. The company highlighted progress in its orexin receptor 2  agonist pipeline, with key data readouts expected within the year. The ORX750 Phase 2a CRYSTAL-1 study is progressing for treating narcolepsy types 1 and 2, and idiopathic hypersomnia, with potential first-in-class results for NT2 and IH anticipated. Furthermore, ORX142 is set to begin first-in-human studies, and ORX489 is advancing in IND-enabling studies for neuropsychiatric disorders. These developments underscore Centessa's commitment to advancing treatments for sleep-wake disorders an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL2NGZqb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","CNTA","IE00BKPKM429.USD","NDAQ","BK4539","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","LU2210149790.SGD","BK4139","BK4585","BK4535"],"gpt_icon":0},{"id":"2535042289","title":"Press Release: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535042289","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535042289?lang=en_us&edition=fundamental","pubTime":"2025-05-14 19:00","pubTimestamp":1747220400,"startTime":"0","endTime":"0","summary":"-- Advancing a broad, potential best-in-class orexin receptor 2 . agonist franchise, with key data readouts expected this year. -- ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy. type 1 , narcolepsy type 2  and idiopathic hypersomnia.  on track with data expected across all three indications this. -- ORX142 on track to initiate first-in-human studies for the. clinical data in acutely sleep-deprived healthy volunteers planned. BOSTON and LONDON, May 14, 2025  -- Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company, today reported financial results and business highlights for the first quarter ended March 31, 2025.Dr. Saha continued, \"We are excited to be at the forefront of developing OX2R agonists starting with ORX750, our most advanced OX2R agonist for the treatment of NT1, NT2 and IH. ORX750 is progressing in the Phase 2a CRYSTAL-1 study and is on track with patient data expected across all three indications this year. Given the unmet patient need f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IH","NSS","R","BK4139","BK4085","BK4022","PK","BK4535","BK4510","BK4547","BK4585","BK4597","BK4215","BK4563","BK4103","BK4232","BK4220","KSS","AAN","BK4539","BK4218","ESS","BK4588","BK4181","BK4178","CNTA"],"gpt_icon":0},{"id":"2533185000","title":"Centessa Pharmaceuticals Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2533185000","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533185000?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:27","pubTimestamp":1746703620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2025 07:27 ET (11:27 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4535","CNTA"],"gpt_icon":0},{"id":"2533901802","title":"Chardan Initiates Centessa Pharmaceuticals at Buy With $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2533901802","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533901802?lang=en_us&edition=fundamental","pubTime":"2025-05-08 18:14","pubTimestamp":1746699270,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals' (CNTA) US stock has an average rating of buy and mean price target of $31.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNTA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-16","symbol":"CNTA","fiscalQuarterEnding":"2021/06","expectedEps":-0.59,"name":null,"time":"","type":"earning","dateTimestamp":1629086400000,"reportTimeType":"","actualEps":-0.65}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNTA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNTA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1748491200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNTA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNTA","date":"2025-06-13","current":-7.18695,"percent":0.283384,"low":-15.558363,"twenty":-7.938378,"median":-4.015666,"eighty":-2.003747,"high":-1.225906,"avg":-5.451578,"sd":3.884382,"marketCap":1608770038},"quantilePoints":[{"date":"2021-05-28","current":-7.692947,"twenty":-7.396809,"median":-6.952601,"eighty":-6.952601,"marketCap":1901481113},{"date":"2021-06-04","current":-8.303545,"twenty":-8.332882,"median":-7.802594,"eighty":-7.10067,"marketCap":2052403735},{"date":"2021-06-11","current":-7.896187,"twenty":-8.332882,"median":-7.945289,"eighty":-7.714876,"marketCap":1951716386},{"date":"2021-06-18","current":-9.060066,"twenty":-8.874923,"median":-8.303545,"eighty":-7.821313,"marketCap":2239394527},{"date":"2021-06-25","current":-8.910944,"twenty":-8.986596,"median":-8.53632,"eighty":-7.904916,"marketCap":2202535765},{"date":"2021-07-02","current":-8.045309,"twenty":-8.90503,"median":-8.340216,"eighty":-7.942015,"marketCap":1988575148},{"date":"2021-07-09","current":-7.976204,"twenty":-8.881375,"median":-8.256262,"eighty":-7.896187,"marketCap":1971494258},{"date":"2021-07-16","current":-7.667049,"twenty":-8.849113,"median":-8.099866,"eighty":-7.802594,"marketCap":1895079752},{"date":"2021-07-23","current":-7.816171,"twenty":-8.739999,"median":-8.045309,"eighty":-7.707057,"marketCap":1931938514},{"date":"2021-07-30","current":-7.507015,"twenty":-8.699991,"median":-7.950744,"eighty":-7.663412,"marketCap":1855524008},{"date":"2021-08-06","current":-7.328797,"twenty":-8.652708,"median":-7.932558,"eighty":-7.634315,"marketCap":1811473292},{"date":"2021-08-13","current":-7.41245,"twenty":-8.478126,"median":-7.825264,"eighty":-7.507015,"marketCap":1832150159},{"date":"2021-08-20","current":-6.613898,"twenty":-8.419932,"median":-7.75434,"eighty":-7.314248,"marketCap":1894180758},{"date":"2021-08-27","current":-6.554257,"twenty":-8.340216,"median":-7.700002,"eighty":-7.266965,"marketCap":1877099868},{"date":"2021-09-03","current":-7.254257,"twenty":-8.303545,"median":-7.667049,"eighty":-6.95605,"marketCap":2077575573},{"date":"2021-09-10","current":-7.018831,"twenty":-8.265719,"median":-7.663412,"eighty":-6.95536,"marketCap":2010151008},{"date":"2021-09-17","current":-5.895064,"twenty":-8.212616,"median":-7.637952,"eighty":-6.840535,"marketCap":1688311088},{"date":"2021-09-24","current":-5.932733,"twenty":-8.123143,"median":-7.590669,"eighty":-6.612642,"marketCap":1699099019},{"date":"2021-10-01","current":-5.185648,"twenty":-8.097684,"median":-7.479737,"eighty":-6.579369,"marketCap":1485138401},{"date":"2021-10-08","current":-4.291029,"twenty":-8.08168,"median":-7.328797,"eighty":-6.507172,"marketCap":1228925057},{"date":"2021-10-15","current":-5.27354,"twenty":-8.051856,"median":-7.303337,"eighty":-5.925827,"marketCap":1510310239},{"date":"2021-10-22","current":-5.33632,"twenty":-7.990025,"median":-7.266965,"eighty":-5.720536,"marketCap":1528290123},{"date":"2021-10-29","current":-5.399101,"twenty":-7.955836,"median":-7.196185,"eighty":-5.556051,"marketCap":1546270006},{"date":"2021-11-05","current":-4.090133,"twenty":-7.950744,"median":-7.018831,"eighty":-5.306186,"marketCap":1171389429},{"date":"2021-11-12","current":-3.839012,"twenty":-7.942015,"median":-6.954325,"eighty":-5.203226,"marketCap":1099469894},{"date":"2021-11-19","current":-3.705089,"twenty":-7.934013,"median":-6.921521,"eighty":-5.09336,"marketCap":1201975246},{"date":"2021-11-26","current":-3.214587,"twenty":-7.910735,"median":-6.730042,"eighty":-5.040625,"marketCap":1042850625},{"date":"2021-12-03","current":-3.524961,"twenty":-7.859088,"median":-6.624885,"eighty":-4.477487,"marketCap":1143539651},{"date":"2021-12-10","current":-3.425198,"twenty":-7.823445,"median":-6.598203,"eighty":-4.221971,"marketCap":1111175321},{"date":"2021-12-17","current":-3.225672,"twenty":-7.808025,"median":-6.569952,"eighty":-4.07381,"marketCap":1046446662},{"date":"2021-12-23","current":-3.461224,"twenty":-7.783292,"median":-6.522867,"eighty":-3.842779,"marketCap":1122862440},{"date":"2021-12-31","current":-3.120366,"twenty":-7.75434,"median":-6.507172,"eighty":-3.613639,"marketCap":1012284314},{"date":"2022-01-07","current":-2.455279,"twenty":-7.735427,"median":-5.986096,"eighty":-3.495032,"marketCap":796522115},{"date":"2022-01-14","current":-2.469135,"twenty":-7.701413,"median":-5.895064,"eighty":-3.44903,"marketCap":801017161},{"date":"2022-01-21","current":-2.491305,"twenty":-7.692132,"median":-5.722419,"eighty":-3.426861,"marketCap":808209234},{"date":"2022-01-28","current":-2.582754,"twenty":-7.684507,"median":-5.662778,"eighty":-3.287747,"marketCap":837876537},{"date":"2022-02-04","current":-2.762882,"twenty":-7.666322,"median":-5.505827,"eighty":-3.221238,"marketCap":896312132},{"date":"2022-02-11","current":-2.635407,"twenty":-7.663412,"median":-5.325333,"eighty":-3.205165,"marketCap":854957711},{"date":"2022-02-18","current":-2.530102,"twenty":-7.66123,"median":-5.260984,"eighty":-3.142536,"marketCap":820795363},{"date":"2022-02-25","current":-2.568898,"twenty":-7.6525,"median":-5.207621,"eighty":-3.053858,"marketCap":833381491},{"date":"2022-03-04","current":-2.133821,"twenty":-7.641589,"median":-5.124437,"eighty":-2.956866,"marketCap":692237053},{"date":"2022-03-11","current":-2.236355,"twenty":-7.634315,"median":-5.088338,"eighty":-2.732399,"marketCap":725500392},{"date":"2022-03-18","current":-2.494076,"twenty":-7.597943,"median":-5.036544,"eighty":-2.649263,"marketCap":809108244},{"date":"2022-03-25","current":-2.449737,"twenty":-7.590669,"median":-4.661433,"eighty":-2.635407,"marketCap":794724097},{"date":"2022-04-01","current":-2.235406,"twenty":-7.510653,"median":-4.429146,"eighty":-2.593839,"marketCap":853701645},{"date":"2022-04-08","current":-2.370811,"twenty":-7.507015,"median":-4.291029,"eighty":-2.5495,"marketCap":905412648},{"date":"2022-04-14","current":-2.191092,"twenty":-7.46337,"median":-4.102689,"eighty":-2.519017,"marketCap":836778044},{"date":"2022-04-22","current":-2.215711,"twenty":-7.420452,"median":-4.069729,"eighty":-2.491305,"marketCap":846180045},{"date":"2022-04-29","current":-2.146778,"twenty":-7.345528,"median":-3.848429,"eighty":-2.476895,"marketCap":819854443},{"date":"2022-05-06","current":-1.967059,"twenty":-7.317158,"median":-3.767342,"eighty":-2.468581,"marketCap":751219839},{"date":"2022-05-13","current":-1.329427,"twenty":-7.311338,"median":-3.602554,"eighty":-2.457497,"marketCap":507708027},{"date":"2022-05-20","current":-2.17336,"twenty":-7.298972,"median":-3.529118,"eighty":-2.44752,"marketCap":427886681},{"date":"2022-05-27","current":-1.996625,"twenty":-7.293152,"median":-3.466766,"eighty":-2.422721,"marketCap":393091501},{"date":"2022-06-03","current":-1.542846,"twenty":-7.277149,"median":-3.455681,"eighty":-2.386116,"marketCap":303752523},{"date":"2022-06-10","current":-1.80556,"twenty":-7.25934,"median":-3.433512,"eighty":-2.354721,"marketCap":355475089},{"date":"2022-06-17","current":-2.354871,"twenty":-7.24484,"median":-3.394715,"eighty":-2.337589,"marketCap":463622272},{"date":"2022-06-24","current":-2.197243,"twenty":-7.20466,"median":-3.303265,"eighty":-2.330032,"marketCap":432588733},{"date":"2022-07-01","current":-2.46951,"twenty":-7.103051,"median":-3.268625,"eighty":-2.315528,"marketCap":486192119},{"date":"2022-07-08","current":-2.822979,"twenty":-7.025299,"median":-3.2229,"eighty":-2.32239,"marketCap":555782481},{"date":"2022-07-15","current":-2.488616,"twenty":-7.012553,"median":-3.214587,"eighty":-2.326211,"marketCap":489953761},{"date":"2022-07-22","current":-2.154253,"twenty":-6.981163,"median":-3.202116,"eighty":-2.326211,"marketCap":424125040},{"date":"2022-07-29","current":-2.063497,"twenty":-6.95536,"median":-3.153621,"eighty":-2.283167,"marketCap":406257245},{"date":"2022-08-05","current":-2.584148,"twenty":-6.952601,"median":-3.098197,"eighty":-2.267445,"marketCap":508761966},{"date":"2022-08-12","current":-1.826021,"twenty":-6.946385,"median":-3.045544,"eighty":-2.241907,"marketCap":401885413},{"date":"2022-08-19","current":-1.645991,"twenty":-6.910848,"median":-2.972107,"eighty":-2.223097,"marketCap":362262908},{"date":"2022-08-26","current":-1.693142,"twenty":-6.840535,"median":-2.82662,"eighty":-2.20328,"marketCap":372640231},{"date":"2022-09-02","current":-2.018911,"twenty":-6.720939,"median":-2.75233,"eighty":-2.174445,"marketCap":444338098},{"date":"2022-09-09","current":-1.73172,"twenty":-6.684526,"median":-2.719928,"eighty":-2.163806,"marketCap":381130767},{"date":"2022-09-16","current":-1.847454,"twenty":-6.635871,"median":-2.654806,"eighty":-2.154164,"marketCap":406602378},{"date":"2022-09-23","current":-1.860313,"twenty":-6.613898,"median":-2.64095,"eighty":-2.146778,"marketCap":409432557},{"date":"2022-09-30","current":-1.723147,"twenty":-6.60762,"median":-2.635407,"eighty":-2.135147,"marketCap":379243981},{"date":"2022-10-07","current":-1.628845,"twenty":-6.598203,"median":-2.60631,"eighty":-2.106487,"marketCap":358489336},{"date":"2022-10-14","current":-1.718861,"twenty":-6.591925,"median":-2.593839,"eighty":-2.073051,"marketCap":378300588},{"date":"2022-10-21","current":-1.581695,"twenty":-6.585647,"median":-2.582754,"eighty":-2.039614,"marketCap":348112013},{"date":"2022-10-28","current":-1.714574,"twenty":-6.554257,"median":-2.560265,"eighty":-2.03177,"marketCap":377357196},{"date":"2022-11-04","current":-1.581695,"twenty":-6.532284,"median":-2.52733,"eighty":-1.993192,"marketCap":348112013},{"date":"2022-11-11","current":-1.436292,"twenty":-6.51345,"median":-2.517276,"eighty":-1.967059,"marketCap":335816676},{"date":"2022-11-18","current":-1.420109,"twenty":-6.507172,"median":-2.5009,"eighty":-1.920323,"marketCap":332032826},{"date":"2022-11-25","current":-1.638587,"twenty":-6.507172,"median":-2.492691,"eighty":-1.863742,"marketCap":383114800},{"date":"2022-12-02","current":-1.561715,"twenty":-6.489594,"median":-2.491305,"eighty":-1.845771,"marketCap":365141513},{"date":"2022-12-09","current":-1.569807,"twenty":-6.128607,"median":-2.488616,"eighty":-1.826021,"marketCap":367033438},{"date":"2022-12-16","current":-1.318962,"twenty":-5.954078,"median":-2.474678,"eighty":-1.815071,"marketCap":308383765},{"date":"2022-12-23","current":-1.327053,"twenty":-5.905109,"median":-2.473097,"eighty":-1.793444,"marketCap":310275690},{"date":"2022-12-30","current":-1.254227,"twenty":-5.89632,"median":-2.469323,"eighty":-1.762571,"marketCap":293248365},{"date":"2023-01-06","current":-1.351329,"twenty":-5.828517,"median":-2.466364,"eighty":-1.75058,"marketCap":315951464},{"date":"2023-01-13","current":-1.496981,"twenty":-5.726186,"median":-2.460822,"eighty":-1.724861,"marketCap":350006113},{"date":"2023-01-20","current":-1.585991,"twenty":-5.720536,"median":-2.455279,"eighty":-1.718861,"marketCap":370817288},{"date":"2023-01-27","current":-1.529348,"twenty":-5.703585,"median":-2.442139,"eighty":-1.706858,"marketCap":357573813},{"date":"2023-02-03","current":-1.464614,"twenty":-5.664661,"median":-2.430339,"eighty":-1.693999,"marketCap":342438414},{"date":"2023-02-10","current":-1.472706,"twenty":-5.641433,"median":-2.415339,"eighty":-1.66828,"marketCap":344330339},{"date":"2023-02-17","current":-1.254227,"twenty":-5.556051,"median":-2.41219,"eighty":-1.654564,"marketCap":293248365},{"date":"2023-02-24","current":-1.347283,"twenty":-5.505827,"median":-2.39543,"eighty":-1.637418,"marketCap":315005502},{"date":"2023-03-03","current":-1.529348,"twenty":-5.399101,"median":-2.385919,"eighty":-1.622404,"marketCap":357573813},{"date":"2023-03-10","current":-1.46866,"twenty":-5.33632,"median":-2.378754,"eighty":-1.614312,"marketCap":343384376},{"date":"2023-03-17","current":-1.577899,"twenty":-5.314347,"median":-2.368706,"eighty":-1.602174,"marketCap":368925363},{"date":"2023-03-24","current":-1.51721,"twenty":-5.27354,"median":-2.354871,"eighty":-1.590036,"marketCap":354735926},{"date":"2023-03-31","current":-1.684476,"twenty":-5.260984,"median":-2.342499,"eighty":-1.585991,"marketCap":364195550},{"date":"2023-04-06","current":-1.6626,"twenty":-5.245917,"median":-2.335764,"eighty":-1.589227,"marketCap":359465738},{"date":"2023-04-14","current":-1.673406,"twenty":-5.214527,"median":-2.326211,"eighty":-1.590036,"marketCap":361802053},{"date":"2023-04-21","current":-2.178502,"twenty":-5.190043,"median":-2.307603,"eighty":-1.59651,"marketCap":471007398},{"date":"2023-04-28","current":-1.958895,"twenty":-5.150491,"median":-2.269873,"eighty":-1.598128,"marketCap":423526813},{"date":"2023-05-05","current":-1.963287,"twenty":-5.114078,"median":-2.250235,"eighty":-1.601365,"marketCap":424476425},{"date":"2023-05-11","current":-2.029169,"twenty":-5.099638,"median":-2.231713,"eighty":-1.602174,"marketCap":438720600},{"date":"2023-05-19","current":-1.966968,"twenty":-5.090849,"median":-2.223097,"eighty":-1.605317,"marketCap":417829143},{"date":"2023-05-26","current":-1.930953,"twenty":-5.084571,"median":-2.208325,"eighty":-1.608554,"marketCap":410178929},{"date":"2023-06-02","current":-2.097493,"twenty":-5.078921,"median":-2.205172,"eighty":-1.610266,"marketCap":445555666},{"date":"2023-06-08","current":-2.08849,"twenty":-5.061343,"median":-2.194167,"eighty":-1.613503,"marketCap":443643410},{"date":"2023-06-16","current":-2.448575,"twenty":-5.032464,"median":-2.194167,"eighty":-1.61551,"marketCap":520133653},{"date":"2023-06-23","current":-2.858171,"twenty":-5.007352,"median":-2.205172,"eighty":-1.617128,"marketCap":607141305},{"date":"2023-06-30","current":-2.655669,"twenty":-4.998563,"median":-2.208325,"eighty":-1.617948,"marketCap":564125104},{"date":"2023-07-06","current":-2.718638,"twenty":-4.994168,"median":-2.208325,"eighty":-1.618358,"marketCap":577501336},{"date":"2023-07-14","current":-3.366791,"twenty":-4.794527,"median":-2.212865,"eighty":-1.618358,"marketCap":715183773},{"date":"2023-07-21","current":-3.281271,"twenty":-4.557845,"median":-2.223097,"eighty":-1.618358,"marketCap":697017341},{"date":"2023-07-28","current":-3.029211,"twenty":-4.471836,"median":-2.23588,"eighty":-1.618358,"marketCap":643474170},{"date":"2023-08-04","current":-3.416302,"twenty":-4.422868,"median":-2.266838,"eighty":-1.620786,"marketCap":725701182},{"date":"2023-08-11","current":-2.943691,"twenty":-4.346904,"median":-2.29203,"eighty":-1.626257,"marketCap":625307738},{"date":"2023-08-18","current":-3.526067,"twenty":-4.299818,"median":-2.321435,"eighty":-1.628837,"marketCap":608768406},{"date":"2023-08-25","current":-3.717885,"twenty":-4.187442,"median":-2.330987,"eighty":-1.628845,"marketCap":641885407},{"date":"2023-09-01","current":-4.253847,"twenty":-4.172569,"median":-2.338806,"eighty":-1.633989,"marketCap":734418205},{"date":"2023-09-08","current":-3.926628,"twenty":-4.199662,"median":-2.352745,"eighty":-1.637886,"marketCap":677924497},{"date":"2023-09-15","current":-3.983045,"twenty":-4.112106,"median":-2.36132,"eighty":-1.641549,"marketCap":687664791},{"date":"2023-09-22","current":-3.43862,"twenty":-4.102222,"median":-2.372144,"eighty":-1.647384,"marketCap":593670949},{"date":"2023-09-29","current":-3.509142,"twenty":-4.100733,"median":-2.381143,"eighty":-1.651224,"marketCap":605846317},{"date":"2023-10-06","current":-3.294757,"twenty":-4.095783,"median":-2.393084,"eighty":-1.654135,"marketCap":568833198},{"date":"2023-10-13","current":-3.464008,"twenty":-4.07381,"median":-2.41219,"eighty":-1.654564,"marketCap":598054082},{"date":"2023-10-20","current":-3.819436,"twenty":-4.029583,"median":-2.413712,"eighty":-1.657778,"marketCap":659417937},{"date":"2023-10-27","current":-3.830719,"twenty":-4.009841,"median":-2.416967,"eighty":-1.660993,"marketCap":661365996},{"date":"2023-11-03","current":-3.864569,"twenty":-3.98643,"median":-2.43311,"eighty":-1.66303,"marketCap":667210173},{"date":"2023-11-10","current":-3.542992,"twenty":-4.008997,"median":-2.445627,"eighty":-1.663137,"marketCap":611690494},{"date":"2023-11-17","current":-4.318817,"twenty":-4.057487,"median":-2.452508,"eighty":-1.666566,"marketCap":679872556},{"date":"2023-11-24","current":-4.186215,"twenty":-4.100338,"median":-2.459436,"eighty":-1.668378,"marketCap":658998078},{"date":"2023-12-01","current":-3.72108,"twenty":-4.100338,"median":-2.466364,"eighty":-1.669014,"marketCap":585776070},{"date":"2023-12-08","current":-4.279242,"twenty":-4.129692,"median":-2.469323,"eighty":-1.670632,"marketCap":673642480},{"date":"2023-12-15","current":-4.34126,"twenty":-4.13318,"median":-2.474286,"eighty":-1.672728,"marketCap":683405415},{"date":"2023-12-22","current":-4.601735,"twenty":-4.186215,"median":-2.475129,"eighty":-1.676041,"marketCap":724409739},{"date":"2023-12-29","current":-4.980045,"twenty":-4.233348,"median":-2.477449,"eighty":-1.678295,"marketCap":783963640},{"date":"2024-01-05","current":-4.521112,"twenty":-4.269319,"median":-2.488616,"eighty":-1.679786,"marketCap":711717925},{"date":"2024-01-12","current":-4.285443,"twenty":-4.295424,"median":-2.491305,"eighty":-1.683637,"marketCap":674618773},{"date":"2024-01-19","current":-4.731973,"twenty":-4.326725,"median":-2.491305,"eighty":-1.684476,"marketCap":744911902},{"date":"2024-01-26","current":-4.856009,"twenty":-4.399965,"median":-2.5009,"eighty":-1.684532,"marketCap":764437771},{"date":"2024-02-02","current":-4.967641,"twenty":-4.429902,"median":-2.517276,"eighty":-1.689713,"marketCap":782011053},{"date":"2024-02-09","current":-4.626542,"twenty":-4.523592,"median":-2.52733,"eighty":-1.695714,"marketCap":728314913},{"date":"2024-02-16","current":-6.716549,"twenty":-4.615379,"median":-2.5566,"eighty":-1.7,"marketCap":1057325806},{"date":"2024-02-23","current":-6.666934,"twenty":-4.717089,"median":-2.560265,"eighty":-1.703429,"marketCap":1049515458},{"date":"2024-03-01","current":-6.518091,"twenty":-4.870893,"median":-2.582754,"eighty":-1.706001,"marketCap":1026084415},{"date":"2024-03-08","current":-6.85919,"twenty":-4.961439,"median":-2.593839,"eighty":-1.706142,"marketCap":1079780555},{"date":"2024-03-15","current":-6.493284,"twenty":-4.983766,"median":-2.60631,"eighty":-1.707927,"marketCap":1022179242},{"date":"2024-03-22","current":-7.491774,"twenty":-5.027178,"median":-2.635407,"eighty":-1.712002,"marketCap":1179362487},{"date":"2024-03-28","current":-6.883997,"twenty":-5.053226,"median":-2.64095,"eighty":-1.714574,"marketCap":1083685729},{"date":"2024-04-05","current":-6.884679,"twenty":-5.086525,"median":-2.652035,"eighty":-1.715431,"marketCap":1040171664},{"date":"2024-04-12","current":-7.880534,"twenty":-5.139139,"median":-2.704687,"eighty":-1.718861,"marketCap":1190630439},{"date":"2024-04-19","current":-6.990903,"twenty":-5.257217,"median":-2.725518,"eighty":-1.719718,"marketCap":1056220600},{"date":"2024-04-26","current":-6.567639,"twenty":-5.386545,"median":-2.762882,"eighty":-1.723147,"marketCap":992271773},{"date":"2024-05-03","current":-7.023623,"twenty":-5.641433,"median":-2.8248,"eighty":-1.724004,"marketCap":1061164103},{"date":"2024-05-10","current":-7.023623,"twenty":-5.727441,"median":-2.858171,"eighty":-1.72829,"marketCap":1061164103},{"date":"2024-05-17","current":-7.220046,"twenty":-5.897575,"median":-2.898681,"eighty":-1.733435,"marketCap":999377119},{"date":"2024-05-24","current":-6.736021,"twenty":-6.045295,"median":-2.956866,"eighty":-1.742008,"marketCap":932379770},{"date":"2024-05-31","current":-6.63155,"twenty":-6.449871,"median":-2.99012,"eighty":-1.748866,"marketCap":917919261},{"date":"2024-06-07","current":-7.284905,"twenty":-6.507172,"median":-3.039628,"eighty":-1.753152,"marketCap":1008354656},{"date":"2024-06-14","current":-8.109765,"twenty":-6.52093,"median":-3.064942,"eighty":-1.76001,"marketCap":1122529342},{"date":"2024-06-21","current":-7.235903,"twenty":-6.562657,"median":-3.109976,"eighty":-1.762233,"marketCap":1001572001},{"date":"2024-06-28","current":-7.333906,"twenty":-6.567639,"median":-3.117294,"eighty":-1.762571,"marketCap":1015137311},{"date":"2024-07-05","current":-7.007229,"twenty":-6.593181,"median":-3.146693,"eighty":-1.762571,"marketCap":969919613},{"date":"2024-07-12","current":-7.815755,"twenty":-6.614162,"median":-3.167477,"eighty":-1.765027,"marketCap":1081833415},{"date":"2024-07-15","current":-8.052596,"twenty":-6.615216,"median":-3.169058,"eighty":-1.765641,"marketCap":1114616245},{"date":"2024-08-02","current":-8.403775,"twenty":-6.626602,"median":-3.170639,"eighty":-1.766572,"marketCap":1163225270},{"date":"2024-08-09","current":-9.310304,"twenty":-6.661354,"median":-3.207659,"eighty":-1.77287,"marketCap":1288704381},{"date":"2024-08-16","current":-9.426834,"twenty":-6.682248,"median":-3.214587,"eighty":-1.785729,"marketCap":1483284121},{"date":"2024-08-23","current":-8.785896,"twenty":-6.734132,"median":-3.2229,"eighty":-1.796016,"marketCap":1382434399},{"date":"2024-08-30","current":-9.390827,"twenty":-6.751278,"median":-3.281096,"eighty":-1.796743,"marketCap":1477618406},{"date":"2024-09-06","current":-10.514269,"twenty":-6.832404,"median":-3.283867,"eighty":-1.79965,"marketCap":1654388707},{"date":"2024-09-13","current":-10.874347,"twenty":-6.868158,"median":-3.290265,"eighty":-1.80556,"marketCap":1711045854},{"date":"2024-09-20","current":-12.951065,"twenty":-6.913304,"median":-3.308277,"eighty":-1.817449,"marketCap":2037811232},{"date":"2024-09-27","current":-12.803987,"twenty":-6.937698,"median":-3.331745,"eighty":-1.81989,"marketCap":2014668896},{"date":"2024-10-04","current":-12.975578,"twenty":-6.954144,"median":-3.371292,"eighty":-1.821735,"marketCap":2041668288},{"date":"2024-10-11","current":-12.795816,"twenty":-6.972141,"median":-3.392691,"eighty":-1.826021,"marketCap":2013383211},{"date":"2024-10-18","current":-12.918381,"twenty":-7.001831,"median":-3.416302,"eighty":-1.826021,"marketCap":2032668490},{"date":"2024-10-25","current":-12.665079,"twenty":-7.018831,"median":-3.424857,"eighty":-1.834594,"marketCap":1992812246},{"date":"2024-10-31","current":-12.330068,"twenty":-7.028433,"median":-3.431835,"eighty":-1.834594,"marketCap":1940099147},{"date":"2024-11-08","current":-13.188025,"twenty":-7.065158,"median":-3.43862,"eighty":-1.838151,"marketCap":2075096106},{"date":"2024-11-15","current":-13.951876,"twenty":-7.136962,"median":-3.458452,"eighty":-1.840054,"marketCap":2249949310},{"date":"2024-11-22","current":-14.871604,"twenty":-7.154148,"median":-3.464008,"eighty":-1.846025,"marketCap":2398269208},{"date":"2024-11-29","current":-14.642684,"twenty":-7.158033,"median":-3.466766,"eighty":-1.850026,"marketCap":2361352475},{"date":"2024-12-06","current":-14.299305,"twenty":-7.20016,"median":-3.483648,"eighty":-1.856884,"marketCap":2305977375},{"date":"2024-12-13","current":-13.792411,"twenty":-7.25934,"median":-3.5035,"eighty":-1.860313,"marketCap":2224233180},{"date":"2024-12-20","current":-14.348359,"twenty":-7.292515,"median":-3.525514,"eighty":-1.862885,"marketCap":2313888103},{"date":"2024-12-27","current":-14.111264,"twenty":-7.307137,"median":-3.529671,"eighty":-1.875375,"marketCap":2275652915},{"date":"2025-01-03","current":-14.30748,"twenty":-7.322546,"median":-3.542992,"eighty":-1.894469,"marketCap":2307295830},{"date":"2025-01-10","current":-13.162882,"twenty":-7.34293,"median":-3.562587,"eighty":-1.906189,"marketCap":2122712163},{"date":"2025-01-17","current":-12.157271,"twenty":-7.41245,"median":-3.587342,"eighty":-1.920323,"marketCap":1960542228},{"date":"2025-01-24","current":-13.310045,"twenty":-7.494505,"median":-3.594241,"eighty":-1.920323,"marketCap":2146444349},{"date":"2025-01-31","current":-13.825114,"twenty":-7.525549,"median":-3.607872,"eighty":-1.928827,"marketCap":2229506999},{"date":"2025-02-07","current":-14.585454,"twenty":-7.63577,"median":-3.644543,"eighty":-1.936166,"marketCap":2352123291},{"date":"2025-02-14","current":-14.405589,"twenty":-7.664139,"median":-3.666467,"eighty":-1.943059,"marketCap":2323117287},{"date":"2025-02-21","current":-13.694303,"twenty":-7.698591,"median":-3.69741,"eighty":-1.945408,"marketCap":2208411723},{"date":"2025-02-28","current":-12.312609,"twenty":-7.79089,"median":-3.70096,"eighty":-1.953754,"marketCap":1985592868},{"date":"2025-03-07","current":-13.702478,"twenty":-7.852827,"median":-3.712244,"eighty":-1.96147,"marketCap":2209730177},{"date":"2025-03-14","current":-13.792411,"twenty":-7.921926,"median":-3.72108,"eighty":-1.963247,"marketCap":2224233180},{"date":"2025-03-21","current":-13.31822,"twenty":-7.950744,"median":-3.729169,"eighty":-1.965496,"marketCap":2147762804},{"date":"2025-03-28","current":-8.19702,"twenty":-8.048224,"median":-3.791227,"eighty":-1.967023,"marketCap":1932504903},{"date":"2025-04-04","current":-7.377883,"twenty":-8.062775,"median":-3.810974,"eighty":-1.967431,"marketCap":1739387597},{"date":"2025-04-11","current":-6.366673,"twenty":-8.048224,"median":-3.829595,"eighty":-1.967851,"marketCap":1500987613},{"date":"2025-04-17","current":-6.683029,"twenty":-8.025357,"median":-3.836361,"eighty":-1.971786,"marketCap":1575570848},{"date":"2025-04-25","current":-7.68859,"twenty":-7.987738,"median":-3.840508,"eighty":-1.982073,"marketCap":1812638989},{"date":"2025-05-02","current":-7.626449,"twenty":-7.96602,"median":-3.853286,"eighty":-1.99062,"marketCap":1797988711},{"date":"2025-05-09","current":-6.999385,"twenty":-7.950744,"median":-3.864569,"eighty":-1.993528,"marketCap":1650154084},{"date":"2025-05-16","current":-7.490824,"twenty":-7.94638,"median":-3.89842,"eighty":-1.995069,"marketCap":1676790953},{"date":"2025-05-23","current":-7.508673,"twenty":-7.936923,"median":-3.940733,"eighty":-1.997279,"marketCap":1680786484},{"date":"2025-05-30","current":-7.776415,"twenty":-7.930432,"median":-3.97314,"eighty":-1.998961,"marketCap":1740719441},{"date":"2025-06-06","current":-7.079504,"twenty":-7.948562,"median":-3.983045,"eighty":-2.001975,"marketCap":1584718659},{"date":"2025-06-13","current":-7.18695,"twenty":-7.938378,"median":-4.015666,"eighty":-2.003747,"marketCap":1608770038}],"updateTime":1750106845199}}}